News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Integral Molecular, Inc. Announces Patent Protecting The Use Of Lipoparticles For Antibody Discovery


3/31/2014 8:33:09 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

PHILADELPHIA--(BUSINESS WIRE)--Integral Molecular, a leader in membrane protein antibody discovery, announces the issuance of a new patent protecting the use of Lipoparticles for eliciting antibodies against membrane protein targets. Lipoparticles are an enabling technology for the company’s MPS Discovery Engine™ for isolating monoclonal antibodies (MAbs) against membrane protein targets. Lipoparticles are used to generate conformationally-sensitive, inhibitory MAbs against targets such as GPCRs, ion channels and transporters. U.S. Patent No. 8,680,244 was issued by the U.S. Patent and Trademark Office on March 25, 2014, further strengthening the intellectual property position of the MPS platform for the discovery of antibody therapeutics.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES